相关实验视频
Updated: Jan 9, 2026

07:40
Multi-Modal Home Sleep Monitoring in Older Adults
Published on: January 26, 2019
8.1K
变化在处方模式和保险覆盖后的多睡眠仪的诊断结果:一个多中心的回顾性研究
Do-Yang Park1, Jae Hoon Cho2, Chan-Soon Park3
1Department of Otorhinolaryngology-Head and Neck Surgery, Ajou University School of Medicine, Suwon, Republic of Korea.
概括
韩国 韩国 韩国 韩国
科学领域:
- 睡眠医学 睡眠医学
- 卫生政策分析 卫生政策分析
- 诊断接入 诊断接入
背景情况:
- 韩国于2018年6月扩大了对多睡眠学 (PSG) 的保险覆盖范围,以改善阻塞性睡眠呼吸暂停 (OSA) 诊断.
- 这一政策旨在提高OSA患者的诊断可访问性.
研究的目的:
- 调查扩大保险覆盖范围对PSG利用率和OSA诊断结果的影响.
- 分析患者人口统计和呼吸暂停-呼吸暂停指数 (AHI) 分布在政策实施后的变化.
主要方法:
- 一项多中心的回顾性研究分析了韩国17家三级医院的数据.
- 包括2015-2023年期间被怀疑患有OSA的患者 (≥20岁),比较覆盖前 (2015-2017) 和覆盖后 (2019-2023) 期间.
- 在两个时期之间比较人口统计数据,PSG率和AHI分布.
主要成果:
- PSG使用率显著增加,从51.3%增加到74.4% (p<0.001).
- 女性患者的比例和平均年龄增加,表明更广泛的访问.
- 平均AHI上升,严重的OSA诊断显著增加 (AHI≥30) 和正常的AHI病例减少 (p<0.001).
结论:
- 扩大了保险覆盖范围,改善了PSG的可访问性,特别是对于老年人,妇女和高风险个人.
- 转向更严重的OSA诊断表明更好地检测未经治疗的病例.
- 调查结果支持包容性卫生政策,同时强调需要对OSA诊断进行适当的患者选择.
更多相关视频
07:54Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
20.5K
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
1.2K
相关概念视频
Blind Procedures
12.8K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.8K
Substance Use Disorders Affecting Sleep
369
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
369
Narcolepsy
466
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
466
Management of Insomnia
507
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
507
Sedatives and Hypnotics Drugs: Miscellaneous Agents
479
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
479